Deep Cultural Understanding
We help you connect with Singapore's diverse cultures by navigating local habits, values, and unspoken norms. This ensures your strategy aligns with local expectations, building trust and fostering sustainable results.
With decades of experience in life science consulting in Singapore, we help clients thrive in this competitive sector. Our firm offers a wide range of services, providing hands-on support to navigate market complexities. Our global reach ensures insights and strategies tailored for success in Singapore.
Singapore’s life science sector is supported by a strong economy, with overall GDP growth of 4.8 % in 2025, and manufacturing—particularly biomedical manufacturing—expanding robustly by 16.3 % for the year. In the fourth quarter of 2025, biomedical manufacturing surged 45.9 % year‑on‑year, while medical technology output rose 8.1 %.
For the life sciences industry specifically, biopharmaceutical manufacturing output in 2024 reached USD 33.77 billion, a 11.5 % decline from the previous year, while the medical technology segment grew 2.7 % to USD 19.98 billion. The industry’s share of total manufacturing output increased to 13.4 %.
The life science analytics sub‑sector is anticipated to grow from US $27.4 million in 2025 to US $59.0 million by 2033, implying a compound annual growth rate (CAGR) of 9.9 %.
Singapore's biomedical manufacturing is projected to expand by
Source: Singapore’s GDP Grew by 5.7 Per Cent in the Fourth Quarter of 2025 and by 4.8 Per Cent in 2025 | Ministry of Trade and Industry
Singapore’s life science landscape is dynamic and rapidly evolving, encompassing biotechnology, pharmaceuticals, medical devices, healthcare IT, diagnostics, agricultural biotech, genomic research, nutraceuticals, bioinformatics, vaccines, clinical research, regenerative medicine, biosimilars, biologics, and telemedicine. Our firm excels in providing life science consulting that addresses the unique needs of these sectors. With a deep understanding of Singapore’s regulatory environment and market trends, we help clients navigate complexities and unlock potential.
Emerging trends in Singapore’s life sciences include personalized medicine, digital health, AI-driven drug discovery, and sustainability in biotech. Our company leverages these innovations to offer targeted insights and strategies, enabling businesses to lead in their respective fields. By fostering collaboration and employing cutting-edge technologies, we ensure clients can adapt and thrive in this competitive market.
Our expertise in life science consulting is grounded in comprehensive industry knowledge and a proven track record of success. We deliver insights and strategies tailored to client goals, facilitating sustainable growth and innovation. As Singapore continues to advance as a global life science hub, our bespoke consulting services empower organizations to seize opportunities and overcome challenges, positioning them at the forefront of industry evolution.
We help you connect with Singapore's diverse cultures by navigating local habits, values, and unspoken norms. This ensures your strategy aligns with local expectations, building trust and fostering sustainable results.
Our actionable intelligence, powered by real-time market monitoring and insights from your ecosystem, enables you to make informed decisions, seize emerging opportunities, and mitigate risks in Singapore's dynamic markets.
Through direct engagement with key stakeholders, we provide you with nuanced perspectives that reveal the “why” behind market behaviors, helping you design tailored solutions that drive meaningful results.
Validate opportunities, manage risk, and allocate capital with greater confidence through current market evidence and practical strategic advice.
Our company has successfully supported various Life Science projects by providing market research, competitive analysis, and strategic guidance to help businesses succeed.
We offers comprehensive Life Science market research, delivering valuable insights and actionable recommendations in Singapore to enable businesses to make well-informed decisions and achieve long-term success in the industry.
We offers comprehensive Life Science Strategic Planning services in Singapore, providing tailored frameworks and actionable strategies to help businesses achieve their goals and sustain growth in a competitive environment.
We delivers expert Life Science Market Entry Strategy solutions in Singapore, offering valuable insights and effective approaches that empower businesses to successfully penetrate new markets and secure a competitive edge.
We provides in-depth Life Science Merger and Acquisitions advisory in Singapore, guiding businesses with expert recommendations to navigate complex transactions, unlock synergies, and maximize shareholder value.
We specializes in Life Science Value Chain Analysis in Singapore, delivering actionable insights that optimize operational efficiency, enhance profitability, and drive strategic decision-making for businesses across industries.
We offers thorough Life Science Competitive Benchmarking services in Singapore, helping businesses identify key performance gaps, uncover market opportunities, and build stronger competitive strategies.
We delivers expert Life Science Distribution and Strategic Partnership solutions in Singapore, enabling businesses to establish effective networks, foster collaborative relationships, and achieve long-term market success.
We provides advanced Life Science Consumer Behavior Analysis services in Singapore, offering actionable insights into consumer preferences and trends to help businesses refine their strategies and enhance customer satisfaction.
Establish industry dominance with our experts and partners
South China Morning Post featured Damien Duhamel, Managing Partner at Eurogroup Consulting, sharing his perspective on how Chinese EV competition could reshape Malaysia's automotive industry and the wider regional market.
At Transport Logistic Southeast Asia 2025, Mickael Feige, Partner at Eurogroup Consulting, moderated a fireside chat on building seamless, smart and sustainable supply chains for the new global economy.
Damien Duhamel shared his perspective with Business Insider on the factors shaping innovation across Asia's leading cities, from human talent and technology to governance and global integration.
Thailand’s ageing transition is creating a real but selective senior living opportunity. The paper examines investable demand, scalable business models and the constraints still limiting market growth.
Southeast Asia is emerging as a key advanced manufacturing hub. The white paper examines the capabilities, technologies and opportunities reshaping the region’s industrial landscape.
Southeast Asia’s cities are transforming through rapid urbanisation and sustainability. It explores the trends shaping greener, more resilient and inclusive urban development.
ASEAN’s consumer landscape is evolving with rising incomes, digitalisation and changing expectations. The report highlights the trends reshaping how businesses engage and grow across the region.
Leading biotech organization — operations spanning Southeast Asia
VIEW DETAILHIDE DETAIL →The client faced challenges in meeting evolving regulatory standards while expanding R&D activities. Complex compliance requirements were impacting timelines and resource allocation. There was a need for a cohesive strategy to streamline regulatory processes.
We conducted an in-depth regulatory framework analysis and collaborated with key stakeholders to redesign compliance workflows. Advanced compliance management tools were implemented to enhance tracking and reporting efficiency. Training workshops were held to ensure stakeholder alignment.
Our recommendation included adopting a phased approach to compliance updates, optimizing resource allocation to critical regulatory areas. We also suggested enhancing internal audit frequencies and introducing a digital compliance dashboard for real-time insights.
Improved compliance efficiency led to a 20% reduction in time to market and a 30% decrease in compliance-related costs within the first year. This positioned the client for smoother regulatory approvals in Singapore and beyond.
Innovative medical device firm — annual revenue of SGD 200 million
VIEW DETAILHIDE DETAIL →The client struggled with high logistics costs and fragmented supply chain operations across the region. Frequent delays and inefficiencies in procurement processes were affecting product availability. The existing system was unable to adapt to rapid market changes.
Our team conducted a comprehensive supply chain audit and leveraged advanced analytics to pinpoint inefficiencies. We implemented a centralized supply chain management system to improve coordination and transparency. Supplier relationships were strengthened with strategic partnerships.
We recommended integrating real-time data analytics into the supply chain, enhancing demand forecasting, and fostering agile logistics practices. Supplier diversification was also encouraged to mitigate risks and enhance resilience.
The result was a 35% reduction in logistics and procurement costs, with delivery times improved by 25%. Supply chain disruptions decreased, enabling better market responsiveness and customer satisfaction.
Emerging nutraceutical company — expanding footprint in Asia
VIEW DETAILHIDE DETAIL →The client aimed to penetrate new markets amidst intense competition and regulatory barriers. Limited brand recognition and distribution networks were hampering growth efforts. Identifying strategic entry points in the Asian market was critical to success.
We assessed market dynamics and developed a comprehensive entry strategy, prioritizing markets with high growth potential. Collaborations with local distribution partners and culturally tailored marketing campaigns were initiated. Distribution channels were optimized for maximum reach.
Our key recommendations involved focusing on digital marketing strategies to enhance brand awareness, leveraging customer insights, and expanding the retail footprint through e-commerce. Regulatory guidance was provided to navigate complex local regulations.
The strategy resulted in a 40% increase in market penetration within the first year and a significant brand visibility boost. Online sales channels contributed to a 50% growth in overall sales, establishing a robust presence in the targeted markets.
Trusted by clients for long-term collaboration. Selected organizations our teams have supported globally and across Singapore.
A market study in Singapore's life sciences sector includes demand analysis, regulatory review, and client segmentation. It evaluates market trends, identifies key players, and assesses potential opportunities and challenges through field interviews and data analysis to provide strategic business insights.
A feasibility study examines the viability of entering the Singapore life sciences market by assessing legal regulations, financial projections, and technical requirements. It helps in understanding market potential, resource allocation, and strategic fit, ensuring informed decision-making before commitments are made.
Market size assessment in Singapore's life sciences industry involves analyzing data from industry reports, conducting competitor benchmarking, and studying historical trends. It uses methodologies like surveys and statistical models to provide a comprehensive view of the market's current and future potential.
Consultants conduct competitive analysis by evaluating competitors' strengths and weaknesses, market positioning, and business strategies. They use methods like SWOT analysis and business process benchmarking to provide insights into competitive dynamics and potential market entry strategies.
Regulatory review in Singapore's life sciences sector involves examining local regulations, compliance requirements, and approval processes. Consultants analyze relevant laws, engage with regulatory bodies, and utilize compliance audits to ensure business operations meet all legal standards and facilitate smooth market entry.
600 N Bridge Rd, #13-06, Singapore 188778